Assoc. Prof. Kasım Diril is the head of the Gene Targeting and Transgenic Models Platform at the Izmir Biomedicine and Genome Center (IBG). After earning his Bachelor's degree from the Department of Molecular Biology and Genetics at Boğaziçi University, he received his Ph.D. from the International Max Planck Research School in Göttingen, Germany, in 2005. He then pursued his postdoctoral research at the National Cancer Institute (NCI, USA) and the Institute of Molecular and Cell Biology (A*STAR, Singapore), respectively. For many years, Dr. Diril conducted research on cell cycle and cancer biology utilizing genetically engineered mouse models. Upon returning to Turkey, he joined Dokuz Eylül University as a faculty member and established the IBG Transgenic Platform in 2020. Dr. Diril's current research and platform activities focus primarily on the in vivo modeling of rare genetic diseases, the optimization of CRISPR-based genome editing methodologies, and the application of assisted reproductive technologies in mice.